Last Week McKesson Corporation (NYSE:MCK) Ratings

May 3, 2018 - By Bridget Boland

McKesson Corporation (NYSE:MCK) Corporate Logo
Big Money Sentiment decreased to 0.79 in Q4 2017. It has change of 0.09, from 2017Q3’s 0.88. The ratio dived due to McKesson Corporation positioning: 73 sold and 310 reduced. 79 funds amassed holdings and 222 increased holdings. Investors holded 180.04 million in 2017Q3 but now own 177.79 million shares or 1.25% less.
Atria Investments holds 0.08% or 10,448 shs. Moreover, Daiwa Grp Incorporated Inc has 0.03% invested in McKesson Corporation (NYSE:MCK). Cibc Ww Inc has invested 0.01% in McKesson Corporation (NYSE:MCK). Texas Permanent School Fund holds 0.11% of its capital in McKesson Corporation (NYSE:MCK) for 56,913 shs. Tnb Fin has invested 0.04% of its capital in McKesson Corporation (NYSE:MCK). Amp Ltd holds 0.16% of its capital in McKesson Corporation (NYSE:MCK) for 192,883 shs. Schroder Inv Mgmt Group accumulated 0.21% or 822,506 shs. Highland Cap Mngmt Lc holds 0.03% or 2,732 shs in its capital. Hillsdale Inv Mngmt has invested 0% in McKesson Corporation (NYSE:MCK). The Connecticut-based Bridgewater Assocs Ltd Partnership has invested 0.06% in McKesson Corporation (NYSE:MCK). State Of Alaska Department Of Revenue reported 21,796 shs stake. Balyasny Asset Mngmt Limited Liability Corporation, Illinois-based fund reported 45,860 shs. Principal Gru Incorporated reported 397,765 shs. Ironwood Invest Mngmt Llc invested in 6,203 shs. Perritt Mngmt Inc holds 0.16% of its capital in McKesson Corporation (NYSE:MCK) for 3,665 shs.

McKesson Corporation had 2 insider sales and 0 insider buys since December 14, 2017. This’s net activity of $10.61 million. On Thursday, December 14 65,000 shs were sold by HAMMERGREN JOHN H, worth $10.40 million.

McKesson Corporation (NYSE:MCK) Ratings Coverage

In total 11 analysts cover McKesson (NYSE:MCK). “Buy” rating has 7, “Sell” are 1, while 3 are “Hold”. 64% are bullish. 14 are the (NYSE:MCK)’s analyst reports since November 9, 2017 according to StockzIntelligence Inc. In Monday, December 18 report Credit Suisse downgraded it to “Sell” rating and $130.0 target. In Thursday, February 1 report RBC Capital Markets maintained it with “Hold” rating and $186.0 target. On Thursday, February 1 the firm has “Hold” rating given by Mizuho. In Wednesday, January 24 report Jefferies upgraded the stock to “Buy” rating. The company rating was maintained by Cowen & Co on Wednesday, April 18. The stock rating was maintained by Mizuho with “Hold” on Wednesday, January 24. On Thursday, November 9 Credit Suisse maintained McKesson Corporation (NYSE:MCK) rating. Credit Suisse has “Sell” rating and $130.0 target. On Friday, February 2 Needham maintained the shares of MCK in report with “Buy” rating. On Wednesday, January 17 Robert W. Baird maintained McKesson Corporation (NYSE:MCK) rating. Robert W. Baird has “Buy” rating and $200.0 target. On Wednesday, April 11 the company was maintained by Bank of America. Listed here are McKesson Corporation (NYSE:MCK) PTs and latest ratings.

18/04/2018 Broker: Cowen & Co Rating: Buy New Target: $186.0000 Maintain
11/04/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $179 New Target: $172 Maintain
08/03/2018 Broker: Barclays Capital Rating: Equal-Weight New Target: $165 Initiates Coverage On
27/02/2018 Broker: Bank of America Rating: Buy New Target: $179.0
02/02/2018 Broker: Needham Rating: Buy New Target: $185.0 Maintain
01/02/2018 Broker: RBC Capital Markets Rating: Hold New Target: $186.0 Maintain
01/02/2018 Broker: Mizuho Rating: Hold New Target: $179.0 Maintain
24/01/2018 Broker: Mizuho Rating: Hold New Target: $186.0 Maintain
24/01/2018 Broker: Jefferies Old Rating: Hold New Rating: Buy Upgrade
17/01/2018 Broker: Robert W. Baird Rating: Buy New Target: $200.0 Maintain

Ticker’s shares touched $154.63 during the last trading session after 0.27% change.McKesson Corporation has volume of 1.51M shares. Since May 3, 2017 MCK has declined 6.57% and is downtrending. The stock underperformed the S&P 500 by 18.12%.

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally.The company has $31.91 billion market cap. The firm operates in two divisions, McKesson Distribution Solutions and McKesson Technology Solutions.The P/E ratio is 6.8. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community oncology and other specialty practices.

McKesson Corporation (NYSE:MCK) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: